HAPILA brings advanced API and synthesis capabilities to Chemspec Europe 2024
HAPILA GmbH (HAPILA) will return for the seventh successive time to the influential Chemspec Europe trade show, this time in Düsseldorf, Germany.
HAPILA has been a consistent presence at Chemspec since 2016 and will again be a prominent exhibitor at the show from Booth J50 in Hall 3 of the Messe Düsseldorf, with a display showcasing its extensive range of CDMO services, including advanced synthesis and API development.
The stand will also represent the work of HAPILA’s strategic marketing and sales partner Transo-Pharm Handels-GmbH, based in Siek near Hamburg, Germany.
The HAPILA team in Düsseldorf will be led by CEO Dr. Uwe Müller. They will emphasize HAPILA’s distinctive identity as both a CDMO as well as CEP-holder of its own API.
© 2026 HAPILA GmbH
Diese Webseite verwendet keine Tracking Tools. Durch Ihren Browser wird ein funktional notwendiges Cookie als Lesebestätigung gespeichert. Unsere Datenschutzrichtline enthält dazu weitere Details.
This website does not use any tracking tools. Your browser stores a cookie that is necessary for functionality to confirm that you have read this notice. Our Privacy Policy contains further details.
